Project measures / variables set:   Maurer1   bwchg

ID, description, units MPD:33266   bwchg   fold change in body weight over testing period   [ratio]  
atenolol, isoproterenol study
Measures • control    • atenolol 10mg    • isoprot 1mg    • isoprot 10mg
Data set, strains Maurer1   inbred   23 strains     sex: m     age: 7-13wks
Procedure body weight
Comparisoncontrol group vs. multiple treatment / dosage groups
Ontology mappings

  SIDE-BY-SIDE STRAIN CURVES
Values
Graph Type
Dimensions Width:  ×  Height: px
Plot Options


  OVERLAPPING STRAIN CURVES
Data
Dimensions px
Toggle Series   
Plot Options

Maurer1 - fold change in body weight over testing period





  ANOVA, Q-Q NORMALITY ASSESSMENT

ANOVA Summary     

Factor DF Sum of squares Mean sum of squares F value p-value (Pr>F)
group 3 0.5095 0.1698 46.4698 < 0.0001
group:strain 66 0.6487 0.0098 2.6896 < 0.0001
Residuals 831 3.0369 0.0037
strain 22 1.6498 0.075 20.5209 < 0.0001

Q-Q normality assessment based on residuals

  


  INDIVIDUAL MEASURES
ProjectIDTreatmentMeasure / Variable Description PanelStrains
tested
SexAge
Maurer1 33266 body weight atenolol, isoproterenol fold change in body weight over testing period   [ratio]   control  bwchg_ctrl inbred 23 m 7-13wks
Maurer1 33267 body weight atenolol, isoproterenol fold change in body weight over testing period   [ratio]   atenolol 10mg  bwchg_at inbred 23 m 7-13wks
Maurer1 33268 body weight atenolol, isoproterenol fold change in body weight over testing period   [ratio]   isoprot 1mg  bwchg_iso1 inbred 23 m 7-13wks
Maurer1 33269 body weight atenolol, isoproterenol fold change in body weight over testing period   [ratio]   isoprot 10mg  bwchg_iso10 inbred 23 m 7-13wks